Hospira sues FDA over generic approvals for its sedative Precedex

August 19, 2014 8:17 PM

7 0

Hospira sues FDA over generic approvals for its sedative Precedex

Shares of Hospira Inc. slipped more than 2% in morning trades Tuesday after the drug maker sued the U.S. Food and Drug Administration over its decision to pave the way for generic forms of Hospira’s Precedex sedative.

Hospira /quotes/zigman/346012/delayed /quotes/zigman/346012/lastsale HSP dropped $1.29 to $54.20 in recent action on the news that the FDA has approved some applications for generic forms of Precedex, often used to anesthetize patients, and seems ready to grant more, the company said.

Read more

To category page

Loading...